Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fmc Corp. (FMC)
NYSE:FMC
Holding FMC?
Track your performance easily
Earnings Data
Report Date
Feb 04, 2025After Close Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$1.65Last Year’s EPS
$1.07Same Quarter Last Year
Moderate Buy
Based on 12 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 29, 2024
|% Change Since: -16.67%
|Next Earnings Date:Feb 04, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive achievements and ongoing challenges. While North America and new products showed strong performance, significant issues in Latin America and pricing pressures were notable. The company is making progress in cost savings and restructuring, but the full-year outlook remains challenging with expected revenue and EBITDA declines.Company Guidance
During FMC Corporation's Q3 2024 earnings call, the company provided detailed guidance, emphasizing a robust performance despite regional challenges. The company highlighted a 9% sales growth, with organic sales increasing by 12% and volume growth of 17%, driven primarily by North America and Brazil. The call underscored the impact of pricing pressures, particularly in Latin America, where two-thirds of the price decline originated from Brazil and Argentina. However, North America outperformed expectations with a 48% increase in sales, attributed to strong volumes and orders from diamide partners. FMC confirmed its full-year guidance, anticipating a 19% sales growth in Q4 and an EPS growth of 54%, driven by new product launches and restructuring cost benefits. The company also aims for cost savings of $125 million to $150 million in 2024, with a gross run rate exceeding $225 million in 2025.Strong North America Performance
North America sales increased 48% due to strong volume growth and increased orders by diamide partners.
New Product Success
New products, including fluindapyr and Isoflex, showed strong growth potential, with expected sales over $100 million in the second half of the year.
Cost Savings and Restructuring Progress
The company is targeting cost benefits from restructuring of $125 million to $150 million in 2024, with greater than $225 million in 2025.
Q3 Sales Growth
Sales growth of 9% was reported above the midpoint of the guidance range, with organic sales growth of 12%.
Adjusted EBITDA Growth
Adjusted EBITDA grew 15% year-over-year, exceeding the high end of the range.
---
FMC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
FMC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2024 | $60.18 | $66.62 | +10.70% |
| Jul 31, 2024 | $57.85 | $63.78 | +10.25% |
| May 06, 2024 | $59.83 | $65.49 | +9.46% |
| Feb 05, 2024 | $58.73 | $51.96 | -11.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Fmc Corp. (FMC) report earnings?
Fmc Corp. (FMC) is schdueled to report earning on Feb 04, 2025, After Close Not Confirmed.
What is Fmc Corp. (FMC) earnings time?
Fmc Corp. (FMC) earnings time is at Feb 04, 2025, After Close Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FMC EPS forecast?
FMC EPS forecast for the fiscal quarter 2024 (Q4) is $1.65.
---